Month: March 2016

Return to news >

The Research Institute at Lindner Center of HOPE is a site for an open label study with the primary goal of validating a signature (model) based on a panel of serum proteomic markers that discriminate Bipolar I, Bipolar II and Major Depression in people seeking treatment for a major depressive episode. The success of this study could lead to the first diagnostic test that would distinguish between the three mood disorders in a person experiencing depressive symptoms.

Lindner Center of HOPE is seeking a total of 90 study participants, between the ages of 18 and 70, with bipolar I depression, bipolar II depression, or major depression, who are currently depressed. Some exclusions apply, so participants should complete a phone screening.

The study duration is 8 weeks and includes 6 visits and 3 blood draws. Subjects will be paid per visit up to a total of $350.

Call 513-536-0707 for more information. All inquiries are kept confidential.

Return to news >

Study May Provide Information About the Safety and Effectiveness of an Investigational Medication

Individuals struggling with binge eating disorder (B.E.D.) feel that their repetitive overeating is out of control. They may feel embarrassed and guilty after eating an excessive amount of food in a set period of time. This is a disorder and not a decision, yet sufferers often can feel shame.

B.E.D. can have a significant impact on people who are suffering. Research and evaluation of investigational medications could lead to treatments that may reduce suffering.

Those diagnosed with B.E.D. may be eligible for a medical research study. Researchers at Lindner Center of HOPE are currently conducting a medical research study evaluating an investigational medication in adults with B.E.D. In this study, the safety and effectiveness of the investigational medication will be evaluated when it is taken daily for 12 weeks.

Those interested in participating in the study must:

  • Be 18 to 55 years of age.
  • Regularly engage in overeating (binge eating) episodes Study-related tests and investigational medication will be provided to eligible participants at no cost. In addition, reimbursement for travel and related expenses may be provided for completed study visits.

Study-related tests and investigational medication will be provided to eligible participants at no cost. In addition, reimbursement for travel and related expenses may be provided for completed study visits.

Lindner Center of HOPE is one site for this national study seeking to have 300 participants.

Call 513-536-0710 for more information. All inquiries are kept confidential.